Chapter One - Ubiquitination and Deubiquitination of G Protein-Coupled Receptors

Progress in Molecular Biology and Translational Science

Volumn 141, Issue , 2016, Pages 1-55

  Jean Charles, P Y ^a   Snyder, J C ^a   Shenoy, S K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

deubiquitination; E3 ubiquitin ligase; early endosomes; lysosomes; trafficking; ubiquitin specific protease

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ADAPTOR PROTEIN; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA CATENIN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; ESCRT PROTEIN; FRIZZLED PROTEIN; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 8; OPIATE RECEPTOR; PARATHYROID HORMONE RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; UBIQUITIN PROTEIN LIGASE; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL SURFACE; CONFORMATIONAL TRANSITION; DEUBIQUITINATION; ENZYME SPECIFICITY; GENE SILENCING; HEDGEHOG SIGNALING; HUMAN; NEUTROPHIL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SACCHAROMYCES CEREVISIAE; TRANS GOLGI NETWORK; UBIQUITINATION; WNT SIGNALING; WW DOMAIN; ANIMAL; BIOLOGICAL MODEL; METABOLISM; WNT SIGNALING PATHWAY;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, G-PROTEIN-COUPLED; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; WNT SIGNALING PATHWAY;

EID: 85007355267     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/bs.pmbts.2016.05.001     Document Type: Chapter

References (241)

1. Lefkowitz, R.J., Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 25:8 (2004), 413–422.
2. Bockaert, J., Pin, J.P., Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:7 (1999), 1723–1729.
3. Lefkowitz, R.J., Shenoy, S.K., Transduction of receptor signals by beta-arrestins. Science 308:5721 (2005), 512–517.
4. Lagerstrom, M.C., Schioth, H.B., Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:4 (2008), 339–357.
5. Whalen, E.J., Rajagopal, S., Lefkowitz, R.J., Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol Med 17:3 (2011), 126–139.
6. Wise, A., Gearing, K., Rees, S., Target validation of G-protein coupled receptors. Drug Discov Today 7:4 (2002), 235–246.
7. Overington, J.P., Al-Lazikani, B., Hopkins, A.L., How many drug targets are there?. Nat Rev Drug Discov 5:12 (2006), 993–996.
8. DeWire, S.M., Ahn, S., Lefkowitz, R.J., Shenoy, S.K., Beta-arrestins and cell signaling. Annu Rev Physiol 69 (2007), 483–510.
9. Benovic, J.L., Kuhn, H., Weyand, I., Codina, J., Caron, M.G., Lefkowitz, R.J., Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 84:24 (1987), 8879–8882.
10. Lohse, M.J., Benovic, J.L., Codina, J., Caron, M.G., Lefkowitz, R.J., Beta-arrestin: a protein that regulates beta-adrenergic receptor function. Science 248:4962 (1990), 1547–1550.
11. Attramadal, H., Arriza, J.L., Aoki, C., Dawson, T.M., Codina, J., Kwatra, M.M., Snyder, S.H., Caron, M.G., Lefkowitz, R.J., Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 267:25 (1992), 17882–17890.
12. Violin, J.D., Lefkowitz, R.J., Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28:8 (2007), 416–422.
13. Shukla, A.K., Xiao, K., Lefkowitz, R.J., Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 36:9 (2011), 457–469.
14. Shenoy, S.K., Lefkowitz, R.J., Beta-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32:9 (2011), 521–533.
15. Claing, A., Laporte, S.A., Caron, M.G., Lefkowitz, R.J., Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol 66:2 (2002), 61–79.
16. Tian, X., Kang, D.S., Benovic, J.L., Beta-arrestins and G protein-coupled receptor trafficking. Handb Exp Pharmacol 219 (2014), 173–186.
17. Luttrell, L.M., Lefkowitz, R.J., The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115:Pt 3 (2002), 455–465.
18. Kang, D.S., Tian, X., Benovic, J.L., Role of beta-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr Opin Cell Biol 27 (2014), 63–71.
19. von Zastrow, M., Role of endocytosis in signalling and regulation of G-protein-coupled receptors. Biochem Soc Trans 29:Pt 4 (2001), 500–504.
20. Shenoy, S.K., Seven-transmembrane receptors and ubiquitination. Circ Res 100:8 (2007), 1142–1154.
21. Drake, M.T., Shenoy, S.K., Lefkowitz, R.J., Trafficking of G protein-coupled receptors. Circ Res 99:6 (2006), 570–582.
22. Premont, R.T., Gainetdinov, R.R., Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69 (2007), 511–534.
23. Qanbar, R., Bouvier, M., Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol Ther 97:1 (2003), 1–33.
24. Torrecilla, I., Tobin, A.B., Co-ordinated covalent modification of G-protein coupled receptors. Curr Pharm Des 12:14 (2006), 1797–1808.
25. Stoffel, R.H., Randall, R.R., Premont, R.T., Lefkowitz, R.J., Inglese, J., Palmitoylation of G protein-coupled receptor kinase, GRK6. Lipid modification diversity in the GRK family. J Biol Chem 269:45 (1994), 27791–27794.
26. Hershko, A., Ciechanover, A., The ubiquitin system. Annu Rev Biochem. 67 (1998), 425–479.
27. Mukhopadhyay, D., Riezman, H., Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315:5809 (2007), 201–205.
28. Varshavsky, A., The ubiquitin system, an immense realm. Annu Rev Biochem 81 (2012), 167–176.
29. Hochstrasser, M., Origin and function of ubiquitin-like proteins. Nature 458:7237 (2009), 422–429.
30. Dikic, I., Wakatsuki, S., Walters, K.J., Ubiquitin-binding domains—from structures to functions. Nat Rev Mol Cell Biol 10:10 (2009), 659–671.
31. Piper, R.C., Dikic, I., Lukacs, G.L., Ubiquitin-dependent sorting in endocytosis. Cold Spring Harb Perspect Biol, 6(1), 2014.
32. Komander, D., Rape, M., The ubiquitin code. Annu Rev Biochem 81 (2012), 203–229.
33. Willis, M.S., Bevilacqua, A., Pulinilkunnil, T., Kienesberger, P., Tannu, M., Patterson, C., The role of ubiquitin ligases in cardiac disease. J Mol Cell Cardiol 71 (2014), 43–53.
34. Ikeda, F., Dikic, I., Atypical ubiquitin chains: new molecular signals. ‘Protein Modifications: Beyond the Usual Suspects’ review series. EMBO Rep 9:6 (2008), 536–542.
35. Hicke, L., Schubert, H.L., Hill, C.P., Ubiquitin-binding domains. Nat Rev Mol Cell Biol 6:8 (2005), 610–621.
36. Dores, M.R., Trejo, J., Ubiquitination of G protein-coupled receptors: functional implications and drug discovery. Mol Pharmacol 82:4 (2012), 563–570.
37. Hislop, J.N., von Zastrow, M., Role of ubiquitination in endocytic trafficking of G-protein-coupled receptors. Traffic 12:2 (2011), 137–148.
38. Alonso, V., Friedman, P.A., Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking. Mol Endocrinol 27:4 (2013), 558–572.
39. Kennedy, J.E., Marchese, A., Regulation of GPCR trafficking by ubiquitin. Prog Mol Biol Transl Sci 132 (2015), 15–38.
40. Hicke, L., A new ticket for entry into budding vesicles-ubiquitin. Cell 106:5 (2001), 527–530.
41. Han, S.O., Xiao, K., Kim, J., Wu, J.H., Wisler, J.W., Nakamura, N., Freedman, N.J., Shenoy, S.K., MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound beta(2)-adrenergic receptors. J Cell Biol 199:5 (2012), 817–830.
42. Henry, A.G., Hislop, J.N., Grove, J., Thorn, K., Marsh, M., von Zastrow, M., Regulation of endocytic clathrin dynamics by cargo ubiquitination. Dev Cell 23:3 (2012), 519–532.
43. Matthys, A., Van Craenenbroeck, K., Lintermans, B., Haegeman, G., Vanhoenacker, P., RhoBTB3 interacts with the 5-HT7a receptor and inhibits its proteasomal degradation. Cell Signal 24:5 (2012), 1053–1063.
44. Milojevic, T., Reiterer, V., Stefan, E., Korkhov, V.M., Dorostkar, M.M., Ducza, E., Ogris, E., Boehm, S., Freissmuth, M., Nanoff, C., The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol 69:4 (2006), 1083–1094.
45. Shenoy, S.K., Xiao, K., Venkataramanan, V., Snyder, P.M., Freedman, N.J., Weissman, A.M., Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J Biol Chem 283:32 (2008), 22166–22176.
46. Berthouze, M., Venkataramanan, V., Li, Y., Shenoy, S.K., The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. EMBO J 28:12 (2009), 1684–1696.
47. Shenoy, S.K., Modi, A.S., Shukla, A.K., Xiao, K., Berthouze, M., Ahn, S., Wilkinson, K.D., Miller, W.E., Lefkowitz, R.J., Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci USA 106:16 (2009), 6650–6655.
48. Xie, L., Xiao, K., Whalen, E.J., Forrester, M.T., Freeman, R.S., Fong, G., Gygi, S.P., Lefkowitz, R.J., Stamler, J.S., Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci Signal, 2(78), 2009, ra33.
49. Li, H., Armando, I., Yu, P., Escano, C., Mueller, S.C., Asico, L., Pascua, A., Lu, Q., Wang, X., Villar, V.A., Jones, J.E., Wang, Z., Periasamy, A., Lau, Y.S., Soares-da-Silva, P., Creswell, K., Guillemette, G., Sibley, D.R., Eisner, G., Gildea, J.J., Felder, R.A., Jose, P.A., Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 118:6 (2008), 2180–2189.
50. Schaeuble, K., Hauser, M.A., Rippl, A.V., Bruderer, R., Otero, C., Groettrup, M., Legler, D.F., Ubiquitylation of the chemokine receptor CCR7 enables efficient receptor recycling and cell migration. J Cell Sci 125:Pt 19 (2012), 4463–4474.
51. Baugher, P.J., Richmond, A., The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis. J Biol Chem 283:45 (2008), 30868–30878.
52. Leclair, H.M., Dubois, S.M., Azzi, S., Dwyer, J., Bidere, N., Gavard, J., Control of CXCR2 activity through its ubiquitination on K327 residue. BMC Cell Biol, 15, 2014, 38.
53. Bhandari, D., Trejo, J., Benovic, J.L., Marchese, A., Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem 282:51 (2007), 36971–36979.
54. Marchese, A., Raiborg, C., Santini, F., Keen, J.H., Stenmark, H., Benovic, J.L., The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev Cell 5:5 (2003), 709–722.
55. Marchese, A., Benovic, J.L., Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 276:49 (2001), 45509–45512.
56. Malik, R., Marchese, A., Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4. Mol Biol Cell 21:14 (2010), 2529–2541.
57. Berlin, I., Higginbotham, K.M., Dise, R.S., Sierra, M.I., Nash, P.D., The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome. J Biol Chem 285:48 (2010), 37895–37908.
58. Mines, M.A., Goodwin, J.S., Limbird, L.E., Cui, F.F., Fan, G.H., Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK ativation. J Biol Chem 284:9 (2009), 5742–5752.
59. Canals, M., Scholten, D.J., de Munnik, S., Han, M.K., Smit, M.J., Leurs, R., Ubiquitination of CXCR7 controls receptor trafficking. PLoS One, 7(3), 2012, e34192.
60. Rondou, P., Haegeman, G., Vanhoenacker, P., Van Craenenbroeck, K., BTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase. J Biol Chem 283:17 (2008), 11083–11096.
61. Rondou, P., Skieterska, K., Packeu, A., Lintermans, B., Vanhoenacker, P., Vauquelin, G., Haegeman, G., Van Craenenbroeck, K., KLHL12-mediated ubiquitination of the dopamine D4 receptor does not target the receptor for degradation. Cell Signal 22:6 (2010), 900–913.
62. Terada, K., Horinouchi, T., Fujioka, Y., Higashi, T., Nepal, P., Horiguchi, M., Karki, S., Hatate, C., Hoshi, A., Harada, T., Mai, Y., Ohba, Y., Miwa, S., Agonist-promoted ubiquitination differentially regulates receptor trafficking of endothelin type A and type B receptors. J Biol Chem 289:51 (2014), 35283–35295.
63. Cohen, B.D., Bariteau, J.T., Magenis, L.M., Dias, J.A., Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway. Endocrinology 144:10 (2003), 4393–4402.
64. Lin, F.T., Lai, Y.J., Makarova, N., Tigyi, G., Lin, W.C., The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. J Biol Chem 282:52 (2007), 37759–37769.
65. Oo, M.L., Thangada, S., Wu, M.T., Liu, C.H., Macdonald, T.L., Lynch, K.R., Lin, C.Y., Hla, T., Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem 282:12 (2007), 9082–9089.
66. Oo, M.L., Chang, S.H., Thangada, S., Wu, M.T., Rezaul, K., Blaho, V., Hwang, S.I., Han, D.K., Hla, T., Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice. J Clin Invest 121:6 (2011), 2290–2300.
67. Cooray, S.N., Guasti, L., Clark, A.J., The E3 ubiquitin ligase Mahogunin ubiquitinates the melanocortin 2 receptor. Endocrinology 152:11 (2011), 4224–4231.
68. Henry, A.G., White, I.J., Marsh, M., von Zastrow, M., Hislop, J.N., The role of ubiquitination in lysosomal trafficking of delta-opioid receptors. Traffic 12:2 (2011), 170–184.
69. Groer, C.E., Schmid, C.L., Jaeger, A.M., Bohn, L.M., Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. J Biol Chem 286:36 (2011), 31731–31741.
70. He, S.Q., Zhang, Z.N., Guan, J.S., Liu, H.R., Zhao, B., Wang, H.B., Li, Q., Yang, H., Luo, J., Li, Z.Y., Wang, Q., Lu, Y.J., Bao, L., Zhang, X., Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation. Neuron 69:1 (2011), 120–131.
71. Tanowitz, M., Von Zastrow, M., Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes. J Biol Chem 277:52 (2002), 50219–50222.
72. Hislop, J.N., Henry, A.G., Marchese, A., von Zastrow, M., Ubiquitination regulates proteolytic processing of G protein-coupled receptors after their sorting to lysosomes. J Biol Chem 284:29 (2009), 19361–19370.
73. Li, J.G., Haines, D.S., Liu-Chen, L.Y., Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation. Mol Pharmacol 73:4 (2008), 1319–1330.
74. Zhan, S., Cai, G.Q., Zheng, A., Wang, Y., Jia, J., Fang, H., Yang, Y., Hu, M., Ding, Q., Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination. Biochim Biophys Acta 1812:4 (2011), 565–571.
75. Dupre, D.J., Chen, Z., Le Gouill, C., Theriault, C., Parent, J.L., Rola-Pleszczynski, M., Stankova, J., Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor. J Biol Chem 278:48 (2003), 48228–48235.
76. Donnellan, P.D., Kinsella, B.T., Immature and mature species of the human Prostacyclin Receptor are ubiquitinated and targeted to the 26S proteasomal or lysosomal degradation pathways, respectively. J Mol Signal, 4, 2009, 7.
77. Grimsey, N.J., Aguilar, B., Smith, T.H., Le, P., Soohoo, A.L., Puthenveedu, M.A., Nizet, V., Trejo, J., Ubiquitin plays an atypical role in GPCR-induced p38 MAP kinase activation on endosomes. J Cell Biol 210:7 (2015), 1117–1131.
78. Wolfe, B.L., Marchese, A., Trejo, J., Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1. J Cell Biol 177:5 (2007), 905–916.
79. Chen, B., Dores, M.R., Grimsey, N., Canto, I., Barker, B.L., Trejo, J., Adaptor protein complex-2 (AP-2) and epsin-1 mediate protease-activated receptor-1 internalization via phosphorylation- and ubiquitination-dependent sorting signals. J Biol Chem 286:47 (2011), 40760–40770.
80. Dores, M.R., Chen, B., Lin, H., Soh, U.J., Paing, M.M., Montagne, W.A., Meerloo, T., Trejo, J., ALIX binds a YPX(3)L motif of the GPCR PAR1 and mediates ubiquitin-independent ESCRT-III/MVB sorting. J Cell Biol 197:3 (2012), 407–419.
81. Dores MR, Lin H, N JG, Mendez F, Trejo J. The alpha-arrestin ARRDC3 mediates ALIX ubiquitination and G protein-coupled receptor lysosomal sorting. Mol Biol Cell. 2015;26(25):4660–4673.
82. Jacob, C., Cottrell, G.S., Gehringer, D., Schmidlin, F., Grady, E.F., Bunnett, N.W., c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J Biol Chem 280:16 (2005), 16076–16087.
83. Hasdemir, B., Murphy, J.E., Cottrell, G.S., Bunnett, N.W., Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2. J Biol Chem 284:41 (2009), 28453–28466.
84. Cottrell, G.S., Padilla, B., Pikios, S., Roosterman, D., Steinhoff, M., Gehringer, D., Grady, E.F., Bunnett, N.W., Ubiquitin-dependent down-regulation of the neurokinin-1 receptor. J Biol Chem 281:38 (2006), 27773–27783.
85. Cook, L.B., Zhu, C.C., Hinkle, P.M., Thyrotropin-releasing hormone receptor processing: role of ubiquitination and proteasomal degradation. Mol Endocrinol 17:9 (2003), 1777–1791.
86. Lahaie, N., Kralikova, M., Prezeau, L., Blahos, J., Bouvier, M., Post-endocytotic deubiquitination and degradation of the metabotropic gamma-aminobutyric acid receptor by the ubiquitin-specific protease 14. J Biol Chem 291:13 (2016), 7156–7170.
87. Martin, N.P., Lefkowitz, R.J., Shenoy, S.K., Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination. J Biol Chem 278:46 (2003), 45954–45959.
88. Zhou, J., Livak, M.F., Bernier, M., Muller, D.C., Carlson, O.D., Elahi, D., Maudsley, S., Egan, J.M., Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. Am J Physiol Endocrinol Metab 293:2 (2007), E538–E547.
89. Alonso, V., Magyar, C.E., Wang, B., Bisello, A., Friedman, P.A., Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting. J Bone Miner Res 26:12 (2011), 2923–2934.
90. Huang, Y., Niwa, J., Sobue, G., Breitwieser, G.E., Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin. J Biol Chem 281:17 (2006), 11610–11617.
91. Zemoura, K., Benke, D., Proteasomal degradation of gamma-aminobutyric acidB receptors is mediated by the interaction of the GABAB2 C terminus with the proteasomal ATPase Rtp6 and regulated by neuronal activity. J Biol Chem 289:11 (2014), 7738–7746.
92. Zemoura, K., Schenkel, M., Acuna, M.A., Yevenes, G.E., Zeilhofer, H.U., Benke, D., Endoplasmic reticulum-associated degradation controls cell surface expression of gamma-aminobutyric acid, type B receptors. J Biol Chem 288:48 (2013), 34897–34905.
93. Moriyoshi, K., Iijima, K., Fujii, H., Ito, H., Cho, Y., Nakanishi, S., Seven in absentia homolog 1A mediates ubiquitination and degradation of group 1 metabotropic glutamate receptors. Proc Natl Acad Sci USA 101:23 (2004), 8614–8619.
94. Alvaro, C.G., O'Donnell, A.F., Prosser, D.C., Augustine, A.A., Goldman, A., Brodsky, J.L., Cyert, M.S., Wendland, B., Thorner, J., Specific alpha-arrestins negatively regulate Saccharomyces cerevisiae pheromone response by down-modulating the G-protein-coupled receptor Ste2. Mol Cell Biol 34:14 (2014), 2660–2681.
95. Paavola, K.J., Stephenson, J.R., Ritter, S.L., Alter, S.P., Hall, R.A., The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity. J Biol Chem 286:33 (2011), 28914–28921.
96. Mukai, A., Yamamoto-Hino, M., Awano, W., Watanabe, W., Komada, M., Goto, S., Balanced ubiquitylation and deubiquitylation of Frizzled regulate cellular responsiveness to Wg/Wnt. EMBO J 29:13 (2010), 2114–2125.
97. Jiang, X., Charlat, O., Zamponi, R., Yang, Y., Cong, F., Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. Mol Cell 58:3 (2015), 522–533.
98. Koo, B.K., Spit, M., Jordens, I., Low, T.Y., Stange, D.E., van de Wetering, M., van Es, J.H., Mohammed, S., Heck, A.J., Maurice, M.M., Clevers, H., Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488:7413 (2012), 665–669.
99. Li, S., Chen, Y., Shi, Q., Yue, T., Wang, B., Jiang, J., Hedgehog-regulated ubiquitination controls smoothened trafficking and cell surface expression in Drosophila. PLoS Biol, 10(1), 2012, e1001239.
100. Xia, R., Jia, H., Fan, J., Liu, Y., Jia, J., USP8 promotes smoothened signaling by preventing its ubiquitination and changing its subcellular localization. PLoS Biol, 10(1), 2012, e1001238.
101. Giordano, F., Simoes, S., Raposo, G., The ocular albinism type 1 (OA1) GPCR is ubiquitinated and its traffic requires endosomal sorting complex responsible for transport (ESCRT) function. Proc Natl Acad Sci USA 108:29 (2011), 11906–11911.
102. Dixon, R.A., Kobilka, B.K., Strader, D.J., Benovic, J.L., Dohlman, H.G., Frielle, T., Bolanowski, M.A., Bennett, C.D., Rands, E., Diehl, R.E., Mumford, R.A., Slater, E.E., Sigal, I.S., Caron, M.G., Lefkowitz, R.J., Strader, C.D., Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321:6065 (1986), 75–79.
103. Lefkowitz, R.J., Seven transmembrane receptors: something old, something new. Acta Physiol 190:1 (2007), 9–19.
104. Kobilka, B.K., Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci 32:4 (2011), 213–218.
105. Rasmussen, S.G., Choi, H.J., Fung, J.J., Pardon, E., Casarosa, P., Chae, P.S., Devree, B.T., Rosenbaum, D.M., Thian, F.S., Kobilka, T.S., Schnapp, A., Konetzki, I., Sunahara, R.K., Gellman, S.H., Pautsch, A., Steyaert, J., Weis, W.I., Kobilka, B.K., Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature 469:7329 (2011), 175–180.
106. Rockman, H.A., Koch, W.J., Lefkowitz, R.J., Seven-transmembrane-spanning receptors and heart function. Nature 415:6868 (2002), 206–212.
107. Lohse, M.J., Engelhardt, S., Eschenhagen, T., What is the role of beta-adrenergic signaling in heart failure?. Circ Res 93:10 (2003), 896–906.
108. Ferguson, S.S., Downey, W.E. 3rd, Colapietro, A.M., Barak, L.S., Menard, L., Caron, M.G., Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:5247 (1996), 363–366.
109. Luttrell, L.M., Ferguson, S.S., Daaka, Y., Miller, W.E., Maudsley, S., Della Rocca, G.J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D.K., Caron, M.G., Lefkowitz, R.J., Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283:5402 (1999), 655–661.
110. Shenoy, S.K., Drake, M.T., Nelson, C.D., Houtz, D.A., Xiao, K., Madabushi, S., Reiter, E., Premont, R.T., Lichtarge, O., Lefkowitz, R.J., Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281:2 (2006), 1261–1273.
111. Nobles, K.N., Xiao, K., Ahn, S., Shukla, A.K., Lam, C.M., Rajagopal, S., Strachan, R.T., Huang, T.Y., Bressler, E.A., Hara, M.R., Shenoy, S.K., Gygi, S.P., Lefkowitz, R.J., Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci Signal, 4(185), 2011, ra51.
112. Shenoy, S.K., McDonald, P.H., Kohout, T.A., Lefkowitz, R.J., Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294:5545 (2001), 1307–1313.
113. Xiao, K., Shenoy, S.K., Beta2-adrenergic receptor lysosomal trafficking is regulated by ubiquitination of lysyl residues in two distinct receptor domains. J Biol Chem 286:14 (2011), 12785–12795.
114. Yao, X., Parnot, C., Deupi, X., Ratnala, V.R., Swaminath, G., Farrens, D., Kobilka, B., Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol 2:8 (2006), 417–422.
115. Ballesteros, J.A., Jensen, A.D., Liapakis, G., Rasmussen, S.G., Shi, L., Gether, U., Javitch, J.A., Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276:31 (2001), 29171–29177.
116. Han, S.O., Kommaddi, R.P., Shenoy, S.K., Distinct roles for beta-arrestin2 and arrestin-domain-containing proteins in beta2 adrenergic receptor trafficking. EMBO Rep 14:2 (2013), 164–171.
117. Ingham, R.J., Colwill, K., Howard, C., Dettwiler, S., Lim, C.S., Yu, J., Hersi, K., Raaijmakers, J., Gish, G., Mbamalu, G., Taylor, L., Yeung, B., Vassilovski, G., Amin, M., Chen, F., Matskova, L., Winberg, G., Ernberg, I., Linding, R., O'Donnell, P., Starostine, A., Keller, W., Metalnikov, P., Stark, C., Pawson, T., WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol 25:16 (2005), 7092–7106.
118. Dodson, E.J., Fishbain-Yoskovitz, V., Rotem-Bamberger, S., Schueler-Furman, O., Versatile communication strategies among tandem WW domain repeats. Exp Biol Med 240:3 (2015), 351–360.
119. Kohout, T.A., Lin, F.S., Perry, S.J., Conner, D.A., Lefkowitz, R.J., Beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA 98:4 (2001), 1601–1606.
120. Aubry, L., Klein, G., True arrestins and arrestin-fold proteins: a structure-based appraisal. Prog Mol Biol Transl Sci 118 (2013), 21–56.
121. Rauch, S., Martin-Serrano, J., Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding. J Virol 85:7 (2011), 3546–3556.
122. Snyder, J.C., Rochelle, L.K., Lyerly, H.K., Caron, M.G., Barak, L.S., Constitutive internalization of the leucine-rich G protein-coupled receptor-5 (LGR5) to the trans-Golgi network. J Biol Chem 288:15 (2013), 10286–10297.
123. Jean-Charles, P.Y., Rajiv, V., Shenoy, S.K., Ubiquitin-related roles of beta-arrestins in endocytic trafficking and signal transduction. J Cell Physiol, 2016 [Epub ahead of print].
124. Hanyaloglu, A.C., McCullagh, E., von Zastrow, M., Essential role of Hrs in a recycling mechanism mediating functional resensitization of cell signaling. EMBO J 24:13 (2005), 2265–2283.
125. Raiborg, C., Bache, K.G., Gillooly, D.J., Madshus, I.H., Stang, E., Stenmark, H., Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat Cell Biol 4:5 (2002), 394–398.
126. Wisler, J.W., DeWire, S.M., Whalen, E.J., Violin, J.D., Drake, M.T., Ahn, S., Shenoy, S.K., Lefkowitz, R.J., A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci USA 104:42 (2007), 16657–16662.
127. Nakamura, N., Fukuda, H., Kato, A., Hirose, S., MARCH-II is a syntaxin-6-binding protein involved in endosomal trafficking. Mol Biol Cell 16:4 (2005), 1696–1710.
128. Fuhs, S.R., Insel, P.A., Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization. J Biol Chem 286:17 (2011), 14830–14841.
129. Shenoy, S.K., Barak, L.S., Xiao, K., Ahn, S., Berthouze, M., Shukla, A.K., Luttrell, L.M., Lefkowitz, R.J., Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J Biol Chem 282:40 (2007), 29549–29562.
130. Wyatt, D., Malik, R., Vesecky, A.C., Marchese, A., Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J Biol Chem 286:5 (2011), 3884–3893.
131. Penela, P., Ruiz-Gomez, A., Castano, J.G., Mayor, F. Jr., Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway. J Biol Chem 273:52 (1998), 35238–35244.
132. Li, X., Baillie, G.S., Houslay, M.D., Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5. J Biol Chem 284:24 (2009), 16170–16182.
133. Lachance, V., Degrandmaison, J., Marois, S., Robitaille, M., Genier, S., Nadeau, S., Angers, S., Parent, J.L., Ubiquitylation and activation of a Rab GTPase is promoted by a beta(2)AR-HACE1 complex. J Cell Sci 127:Pt 1 (2014), 111–123.
134. Liang, W., Hoang, Q., Clark, R.B., Fishman, P.H., Accelerated dephosphorylation of the beta2-adrenergic receptor by mutation of the C-terminal lysines: effects on ubiquitination, intracellular trafficking, and degradation. Biochemistry 47:45 (2008), 11750–11762.
135. Kommaddi, R.P., Jean-Charles, P.Y., Shenoy, S.K., Phosphorylation of the deubiquitinase USP20 by protein kinase A regulates post-endocytic trafficking of beta2 adrenergic receptors to autophagosomes during physiological stress. J Biol Chem 290:14 (2015), 8888–8903.
136. Wang, J., Knaut, H., Chemokine signaling in development and disease. Development 141:22 (2014), 4199–4205.
137. Murdoch, C., Finn, A., Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:10 (2000), 3032–3043.
138. Hirsch, E., Katanaev, V.L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., Wymann, M.P., Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287:5455 (2000), 1049–1053.
139. Scandella, E., Men, Y., Legler, D.F., Gillessen, S., Prikler, L., Ludewig, B., Groettrup, M., CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103:5 (2004), 1595–1601.
140. Zlotnik, A., Yoshie, O., The chemokine superfamily revisited. Immunity 36:5 (2012), 705–716.
141. Griffith, J.W., Sokol, C.L., Luster, A.D., Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32 (2014), 659–702.
142. Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C.M., Gerard, N.P., Gerard, C., Lefkowitz, R.J., Beta-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7. Proc Natl Acad Sci USA 107:2 (2010), 628–632.
143. Vacchini, A., Locati, M., Borroni, E.M., Overview and potential unifying themes of the atypical chemokine receptor family. J Leukoc Biol, 2016 [Epub ahead of print].
144. Feniger-Barish, R., Belkin, D., Zaslaver, A., Gal, S., Dori, M., Ran, M., Ben-Baruch, A., GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling. Blood 95:5 (2000), 1551–1559.
145. Richardson, R.M., Marjoram, R.J., Barak, L.S., Snyderman, R., Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J Immunol 170:6 (2003), 2904–2911.
146. Busillo, J.M., Benovic, J.L., Regulation of CXCR4 signaling. Biochim Biophys Acta 1768:4 (2007), 952–963.
147. Qin, L., Kufareva, I., Holden, L.G., Wang, C., Zheng, Y., Zhao, C., Fenalti, G., Wu, H., Han, G.W., Cherezov, V., Abagyan, R., Stevens, R.C., Handel, T.M., Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine. Science 347:6226 (2015), 1117–1122.
148. Busillo, J.M., Armando, S., Sengupta, R., Meucci, O., Bouvier, M., Benovic, J.L., Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem 285:10 (2010), 7805–7817.
149. Bhandari, D., Robia, S.L., Marchese, A., The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction. Mol Biol Cell 20:5 (2009), 1324–1339.
150. Malik, R., Soh, U.J., Trejo, J., Marchese, A., Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling. J Biol Chem 287:12 (2012), 9013–9027.
151. Holleman, J., Marchese, A., The ubiquitin ligase deltex-3l regulates endosomal sorting of the G protein-coupled receptor CXCR4. Mol Biol Cell 25:12 (2014), 1892–1904.
152. Balabanian, K., Lagane, B., Infantino, S., Chow, K.Y., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., Bachelerie, F., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280:42 (2005), 35760–35766.
153. Miao, Z., Luker, K.E., Summers, B.C., Berahovich, R., Bhojani, M.S., Rehemtulla, A., Kleer, C.G., Essner, J.J., Nasevicius, A., Luker, G.D., Howard, M.C., Schall, T.J., CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104:40 (2007), 15735–15740.
154. Zabel, B.A., Lewen, S., Berahovich, R.D., Jaen, J.C., Schall, T.J., The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol Cancer, 10, 2011, 73.
155. Forster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E., Lipp, M., CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:1 (1999), 23–33.
156. Forster, R., Davalos-Misslitz, A.C., Rot, A., CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8:5 (2008), 362–371.
157. Kohout, T.A., Nicholas, S.L., Perry, S.J., Reinhart, G., Junger, S., Struthers, R.S., Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 279:22 (2004), 23214–23222.
158. Zidar, D.A., Violin, J.D., Whalen, E.J., Lefkowitz, R.J., Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc Natl Acad Sci USA 106:24 (2009), 9649–9654.
159. Zhang, C., Srinivasan, Y., Arlow, D.H., Fung, J.J., Palmer, D., Zheng, Y., Green, H.F., Pandey, A., Dror, R.O., Shaw, D.E., Weis, W.I., Coughlin, S.R., Kobilka, B.K., High-resolution crystal structure of human protease-activated receptor 1. Nature 492:7429 (2012), 387–392.
160. Ramachandran, R., Noorbakhsh, F., Defea, K., Hollenberg, M.D., Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 11:1 (2012), 69–86.
161. Adams, M.N., Ramachandran, R., Yau, M.K., Suen, J.Y., Fairlie, D.P., Hollenberg, M.D., Hooper, J.D., Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 130:3 (2011), 248–282.
162. Coughlin, S.R., How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:20 (1999), 11023–11027.
163. Paing, M.M., Stutts, A.B., Kohout, T.A., Lefkowitz, R.J., Trejo, J., Beta-Arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J Biol Chem 277:2 (2002), 1292–1300.
164. Ayoub, M.A., Trinquet, E., Pfleger, K.D., Pin, J.P., Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1. FASEB J 24:9 (2010), 3522–3535.
165. DeFea, K.A., Zalevsky, J., Thoma, M.S., Dery, O., Mullins, R.D., Bunnett, N.W., Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:6 (2000), 1267–1281.
166. Walker, J.K., DeFea, K.A., Role for beta-arrestin in mediating paradoxical beta2AR and PAR2 signaling in asthma. Curr Opin Pharmacol 16 (2014), 142–147.
167. Ossovskaya, V.S., Bunnett, N.W., Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:2 (2004), 579–621.
168. Soh, U.J., Dores, M.R., Chen, B., Trejo, J., Signal transduction by protease-activated receptors. Br J Pharmacol 160:2 (2010), 191–203.
169. Dores, M.R., Paing, M.M., Lin, H., Montagne, W.A., Marchese, A., Trejo, J., AP-3 regulates PAR1 ubiquitin-independent MVB/lysosomal sorting via an ALIX-mediated pathway. Mol Biol Cell 23:18 (2012), 3612–3623.
170. Stalheim, L., Ding, Y., Gullapalli, A., Paing, M.M., Wolfe, B.L., Morris, D.R., Trejo, J., Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Mol Pharmacol 67:1 (2005), 78–87.
171. Waldhoer, M., Bartlett, S.E., Whistler, J.L., Opioid receptors. Annu Rev Biochem 73 (2004), 953–990.
172. Hislop, J.N., Marley, A., Von Zastrow, M., Role of mammalian vacuolar protein-sorting proteins in endocytic trafficking of a non-ubiquitinated G protein-coupled receptor to lysosomes. J Biol Chem 279:21 (2004), 22522–22531.
173. Petaja-Repo, U.E., Hogue, M., Laperriere, A., Bhalla, S., Walker, P., Bouvier, M., Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276:6 (2001), 4416–4423.
174. Kim, J.A., Bartlett, S., He, L., Nielsen, C.K., Chang, A.M., Kharazia, V., Waldhoer, M., Ou, C.J., Taylor, S., Ferwerda, M., Cado, D., Whistler, J.L., Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol 18:2 (2008), 129–135.
175. Zhang, J., Ferguson, S.S., Barak, L.S., Bodduluri, S.R., Laporte, S.A., Law, P.Y., Caron, M.G., Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:12 (1998), 7157–7162.
176. Bohn, L.M., Gainetdinov, R.R., Lin, F.T., Lefkowitz, R.J., Caron, M.G., Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:6813 (2000), 720–723.
177. Bohn, L.M., Gainetdinov, R.R., Sotnikova, T.D., Medvedev, I.O., Lefkowitz, R.J., Dykstra, L.A., Caron, M.G., Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23:32 (2003), 10265–10273.
178. Bohn, L.M., Lefkowitz, R.J., Caron, M.G., Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 22:23 (2002), 10494–10500.
179. Bohn, L.M., Lefkowitz, R.J., Gainetdinov, R.R., Peppel, K., Caron, M.G., Lin, F.T., Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:5449 (1999), 2495–2498.
180. Bohn, L.M., Dykstra, L.A., Lefkowitz, R.J., Caron, M.G., Barak, L.S., Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 66:1 (2004), 106–112.
181. Hislop, J.N., Henry, A.G., von Zastrow, M., Ubiquitination in the first cytoplasmic loop of mu-opioid receptors reveals a hierarchical mechanism of lysosomal down-regulation. J Biol Chem 286:46 (2011), 40193–40204.
182. Krishnan, A., Almen, M.S., Fredriksson, R., Schioth, H.B., The origin of GPCRs: identification of mammalian like Rhodopsin, Adhesion, Glutamate and Frizzled GPCRs in fungi. PLoS One, 7(1), 2012, e29817.
183. Briscoe, J., Therond, P.P., The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol 14:7 (2013), 416–429.
184. Dijksterhuis, J.P., Petersen, J., Schulte, G., WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR review 3. Br J Pharmacol 171:5 (2014), 1195–1209.
185. Villanueva, H., Visbal, A.P., Obeid, N.F., Ta, A.Q., Faruki, A.A., Wu, M.F., Hilsenbeck, S.G., Shaw, C.A., Yu, P., Plummer, N.W., Birnbaumer, L., Lewis, M.T., An essential role for Galpha(i2) in Smoothened-stimulated epithelial cell proliferation in the mammary gland. Sci Signal, 8(394), 2015, ra92.
186. MacDonald, B.T., Tamai, K., He, X., Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:1 (2009), 9–26.
187. Clevers, H., Nusse, R., Wnt/beta-catenin signaling and disease. Cell 149:6 (2012), 1192–1205.
188. Madan, B., Virshup, D.M., Targeting Wnts at the source–new mechanisms, new biomarkers, new drugs. Mol Cancer Ther 14:5 (2015), 1087–1094.
189. Zimmerman, Z.F., Moon, R.T., Chien, A.J., Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol, 4(11), 2012.
190. Hao, H.X., Xie, Y., Zhang, Y., Charlat, O., Oster, E., Avello, M., Lei, H., Mickanin, C., Liu, D., Ruffner, H., Mao, X., Ma, Q., Zamponi, R., Bouwmeester, T., Finan, P.M., Kirschner, M.W., Porter, J.A., Serluca, F.C., Cong, F., ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:7397 (2012), 195–200.
191. de Lau, W., Peng, W.C., Gros, P., Clevers, H., The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. Genes Dev 28:4 (2014), 305–316.
192. Hsu, S.Y., Liang, S.-G., Hsueh, A.J.W., Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Molecular Endocrinology 12:12 (1998), 1830–1845.
193. Hsu, S.Y., Kudo, M., Chen, T., Nakabayashi, K., Bhalla, A., van der Spek, P.J., van Duin, M., Hsueh, A.J., The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol 14:8 (2000), 1257–1271.
194. McDonald, T., Wang, R., Bailey, W., Xie, G., Chen, F., Caskey, C.T., Liu, Q., Identification and cloning of an orphan G protein-coupled receptor of the glycoprotein hormone receptor subfamily. Biochem Biophys Res Commun 247:2 (1998), 266–270.
195. Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., Clevers, H., Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:7165 (2007), 1003–1007.
196. de Lau, W., Barker, N., Low, T.Y., Koo, B.K., Li, V.S., Teunissen, H., Kujala, P., Haegebarth, A., Peters, P.J., van de Wetering, M., Stange, D.E., van Es, J.E., Guardavaccaro, D., Schasfoort, R.B., Mohri, Y., Nishimori, K., Mohammed, S., Heck, A.J., Clevers, H., Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:7360 (2011), 293–297.
197. Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A.R., Sansom, O.J., Clevers, H., Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457:7229 (2009), 608–611.
198. Schepers, A.G., Snippert, H.J., Stange, D.E., van den Born, M., van Es, J.H., van de Wetering, M., Clevers, H., Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337:6095 (2012), 730–735.
199. Carmon, K.S., Gong, X., Lin, Q., Thomas, A., Liu, Q., R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci USA 108:28 (2011), 11452–11457.
200. Glinka, A., Dolde, C., Kirsch, N., Huang, Y.L., Kazanskaya, O., Ingelfinger, D., Boutros, M., Cruciat, C.M., Niehrs, C., LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep 12:10 (2011), 1055–1061.
201. Carmon, K.S., Lin, Q., Gong, X., Thomas, A., Liu, Q., LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt/beta-catenin signaling. Mol Cell Biol 32:11 (2012), 2054–2064.
202. Snyder, J.C., Rochelle, L.K., Barak, L.S., Caron, M.G., The stem cell-expressed receptor Lgr5 possesses canonical and functionally active molecular determinants critical to beta-arrestin-2 recruitment. PLoS One, 8(12), 2013, e84476.
203. Xie, Y., Zamponi, R., Charlat, O., Ramones, M., Swalley, S., Jiang, X., Rivera, D., Tschantz, W., Lu, B., Quinn, L., Dimitri, C., Parker, J., Jeffery, D., Wilcox, S.K., Watrobka, M., LeMotte, P., Granda, B., Porter, J.A., Myer, V.E., Loew, A., Cong, F., Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin. EMBO Rep 14:12 (2013), 1120–1126.
204. Chen, P.H., Chen, X., Lin, Z., Fang, D., He, X., The structural basis of R-spondin recognition by LGR5 and RNF43. Genes Dev 27:12 (2013), 1345–1350.
205. Zebisch, M., Jones, E.Y., Crystal structure of R-spondin 2 in complex with the ectodomains of its receptors LGR5 and ZNRF3. J Struct Biol 191:2 (2015), 149–155.
206. Arensdorf, A.M., Marada, S., Ogden, S.K., Smoothened regulation: a tale of two signals. Trends Pharmacol Sci 37:1 (2016), 62–72.
207. Chen, W., Ren, X.R., Nelson, C.D., Barak, L.S., Chen, J.K., Beachy, P.A., de Sauvage, F., Lefkowitz, R.J., Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science 306:5705 (2004), 2257–2260.
208. Wilbanks, A.M., Fralish, G.B., Kirby, M.L., Barak, L.S., Li, Y.X., Caron, M.G., Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science 306:5705 (2004), 2264–2267.
209. Meloni, A.R., Fralish, G.B., Kelly, P., Salahpour, A., Chen, J.K., Wechsler-Reya, R.J., Lefkowitz, R.J., Caron, M.G., Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol Cell Biol 26:20 (2006), 7550–7560.
210. Kovacs, J.J., Whalen, E.J., Liu, R., Xiao, K., Kim, J., Chen, M., Wang, J., Chen, W., Lefkowitz, R.J., β-Arrestin–mediated localization of smoothened to the primary cilium. Science 320:5884 (2008), 1777–1781.
211. Theodosiou, N.A., Zhang, S., Wang, W.Y., Xu, T., slimb coordinates wg and dpp expression in the dorsal-ventral and anterior-posterior axes during limb development. Development 125:17 (1998), 3411–3416.
212. Zhao, Y., Tong, C., Jiang, J., Hedgehog regulates smoothened activity by inducing a conformational switch. Nature 450:7167 (2007), 252–258.
213. Yang, X., Mao, F., Lv, X., Zhang, Z., Fu, L., Lu, Y., Wu, W., Zhou, Z., Zhang, L., Zhao, Y., Drosophila Vps36 regulates Smo trafficking in Hedgehog signaling. J Cell Sci 126:Pt 18 (2013), 4230–4238.
214. Fan, J., Jiang, K., Liu, Y., Jia, J., Hrs promotes ubiquitination and mediates endosomal trafficking of smoothened in Drosophila hedgehog signaling. PLoS One, 8(11), 2013, e79021.
215. Huang, S., Zhang, Z., Zhang, C., Lv, X., Zheng, X., Chen, Z., Sun, L., Wang, H., Zhu, Y., Zhang, J., Yang, S., Lu, Y., Sun, Q., Tao, Y., Liu, F., Zhao, Y., Chen, D., Activation of SMURF E3 ligase promoted by smoothened regulates hedgehog signaling through targeting patched turnover. PLoS Biol, 11(11), 2013, e1001721.
216. Yue, S., Tang, L.Y., Tang, Y., Tang, Y., Shen, Q.H., Ding, J., Chen, Y., Zhang, Z., Yu, T.T., Zhang, Y.E., Cheng, S.Y., Requirement of SMURF-mediated endocytosis of Patched1 in sonic hedgehog signal reception. Elife, 3, 2014.
217. Brigui, A., Hofmann, L., Arguelles, C., Sanial, M., Holmgren, R.A., Plessis, A., Control of the dynamics and homeostasis of the Drosophila Hedgehog receptor Patched by two C2-WW-HECT-E3 Ubiquitin ligases. Open Biol, 5(10), 2015.
218. Dohlman, H.G., Thorner, J.W., Regulation of G protein-initiated signal transduction in yeast: paradigms and principles. Annu Rev Biochem 70 (2001), 703–754.
219. Feng, Y., Davis, N.G., Akr1p and the type I casein kinases act prior to the ubiquitination step of yeast endocytosis: Akr1p is required for kinase localization to the plasma membrane. Mol Cell Biol 20:14 (2000), 5350–5359.
220. Dunn, R., Hicke, L., Domains of the Rsp5 ubiquitin-protein ligase required for receptor-mediated and fluid-phase endocytosis. Mol Biol Cell 12:2 (2001), 421–435.
221. Lin, C.H., MacGurn, J.A., Chu, T., Stefan, C.J., Emr, S.D., Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell 135:4 (2008), 714–725.
222. Feng, Y., Davis, N.G., Feedback phosphorylation of the yeast a-factor receptor requires activation of the downstream signaling pathway from G protein through mitogen-activated protein kinase. Mol Cell Biol 20:2 (2000), 563–574.
223. Ye, Y., Scheel, H., Hofmann, K., Komander, D., Dissection of USP catalytic domains reveals five common insertion points. Mol Biosyst 5:12 (2009), 1797–1808.
224. Gesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C.D., Wang, S., Eckhardt, A.E., Cowan, C.L., Spurney, R.F., Luttrell, L.M., Lefkowitz, R.J., Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem 281:16 (2006), 10856–10864.
225. Hasdemir, B., Bunnett, N.W., Cottrell, G.S., Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) mediates post-endocytic trafficking of protease-activated receptor 2 and calcitonin receptor-like receptor. J Biol Chem 282:40 (2007), 29646–29657.
226. Wright, M.H., Berlin, I., Nash, P.D., Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination. Cell Biochem Biophys 60:1–2 (2011), 39–46.
227. Row, P.E., Liu, H., Hayes, S., Welchman, R., Charalabous, P., Hofmann, K., Clague, M.J., Sanderson, C.M., Urbe, S., The M.I.T. domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation. J Biol Chem 282:42 (2007), 30929–30937.
228. Ali, N., Zhang, L., Taylor, S., Mironov, A., Urbe, S., Woodman, P., Recruitment of UBPY and ESCRT exchange drive HD-PTP-dependent sorting of EGFR to the MVB. Curr Biol 23:6 (2013), 453–461.
229. Gassmann, M., Bettler, B., Regulation of neuronal GABA(B) receptor functions by subunit composition. Nat Rev Neurosci 13:6 (2012), 380–394.
230. Grampp, T., Sauter, K., Markovic, B., Benke, D., Gamma-aminobutyric acid type B receptors are constitutively internalized via the clathrin-dependent pathway and targeted to lysosomes for degradation. J Biol Chem 282:33 (2007), 24157–24165.
231. Kanaide, M., Uezono, Y., Matsumoto, M., Hojo, M., Ando, Y., Sudo, Y., Sumikawa, K., Taniyama, K., Desensitization of GABA(B) receptor signaling by formation of protein complexes of GABA(B2) subunit with GRK4 or GRK5. J Cell Physiol 210:1 (2007), 237–245.
232. Perroy, J., Adam, L., Qanbar, R., Chenier, S., Bouvier, M., Phosphorylation-independent desensitization of GABA(B) receptor by GRK4. EMBO J 22:15 (2003), 3816–3824.
233. Terunuma, M., Pangalos, M.N., Moss, S.J., Functional modulation of GABAB receptors by protein kinases and receptor trafficking. Adv Pharmacol 58 (2010), 113–122.
234. Hu, M., Li, P., Song, L., Jeffrey, P.D., Chenova, T.A., Wilkinson, K.D., Cohen, R.E., Shi, Y., Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J 24:21 (2005), 3747–3756.
235. Borodovsky, A., Kessler, B.M., Casagrande, R., Overkleeft, H.S., Wilkinson, K.D., Ploegh, H.L., A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J 20:18 (2001), 5187–5196.
236. Lee, B.H., Lee, M.J., Park, S., Oh, D.C., Elsasser, S., Chen, P.C., Gartner, C., Dimova, N., Hanna, J., Gygi, S.P., Wilson, S.M., King, R.W., Finley, D., Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467:7312 (2010), 179–184.
237. Haraguchi, K., Rodbell, M., Isoproterenol stimulates shift of G proteins from plasma membrane to pinocytotic vesicles in rat adipocytes: a possible means of signal dissemination. Proc Natl Acad Sci USA 87:3 (1990), 1208–1212.
238. Ferrandon, S., Feinstein, T.N., Castro, M., Wang, B., Bouley, R., Potts, J.T., Gardella, T.J., Vilardaga, J.P., Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5:10 (2009), 734–742.
239. Calebiro, D., Nikolaev, V.O., Lohse, M.J., Imaging of persistent cAMP signaling by internalized G protein-coupled receptors. J Mol Endocrinol 45:1 (2010), 1–8.
240. Irannejad, R., Tomshine, J.C., Tomshine, J.R., Chevalier, M., Mahoney, J.P., Steyaert, J., Rasmussen, S.G., Sunahara, R.K., El-Samad, H., Huang, B., von Zastrow, M., Conformational biosensors reveal GPCR signalling from endosomes. Nature 495:7442 (2013), 534–538.
241. Luttrell, L.M., Roudabush, F.L., Choy, E.W., Miller, W.E., Field, M.E., Pierce, K.L., Lefkowitz, R.J., Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 98:5 (2001), 2449–2454.